Molecular pathogenesis and mechanisms of thyroid cancer
Top Cited Papers
- 22 February 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 13 (3), 184-199
- https://doi.org/10.1038/nrc3431
Abstract
No abstract availableKeywords
This publication has 153 references indexed in Scilit:
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Uncommon GNAQ, MMP8, AKT3, EGFR, and PIK3R1 Mutations in Thyroid CancersEndocrine Pathology, 2011
- The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumorsMolecular and Cellular Endocrinology, 2010
- The role of the PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancerMolecular and Cellular Endocrinology, 2010
- Prognostic utility of BRAF mutation in papillary thyroid cancerMolecular and Cellular Endocrinology, 2010
- Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancerBiochemical and Biophysical Research Communications, 2010
- BRAF mutation‐selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic‐potentiated synergism with the mTOR inhibitor temsirolimusInternational Journal of Cancer, 2010
- IQGAPs in cancer: A family of scaffold proteins underlying tumorigenesisFEBS Letters, 2009
- Recent Advances in Molecular Biology of Thyroid Cancer and Their Clinical ImplicationsOtolaryngologic Clinics of North America, 2008
- A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life SpanCell, 2006